Skip to content
AZBio Logo
  • Members
    • AZBio Member Directory
      • Member Login
    • Join AZBio
    • Support AZBio
    • Save with AZBio Purchasing Power
  • AZBio News
    • Voice of the Patient
    • Resources for Media
      • 3rd Party Content
  • Events
    • 2026 State Bio Friends Reception
    • AZBio Day at The Capitol
    • Arizona Bioscience Week 2026
      • Looking Back at AZBW 2025
      • Looking Back at AZBW 2024
    • AZBio Awards 2026
    • White Hat 2026
  • Advocacy
    • AZBio Legislative Watch List for 2026
    • Request to Speak Instructions
    • AZBio Public Policy Principles
    • Arizona Congressional Delegation
    • 2026 Congressional Calendar
  • Resources
    • AZBioPEERS
    • AZBio PEERS Mentoring Program
    • Cost Saving Programs
    • Core Facilities
    • Arizona Life Science Infrastructure
    • Clinical Trials in Arizona
    • AZBio Career Center
    • Arizona BioMap
  • About AZBio
    • What We Do
    • AZBio Board of Directors
    • AZBio Staff
    • Arizona Bioindustry Fact Sheet
    • AZBio History
  • Menu

Category Archives: Inside the Belt Way

AdvaMed Outlines Four Key Priorities in Letter to President on Sterilization

Posted on Mon/23/JanuaryMon/23/January by AZBio

WASHINGTON, D.C. – In a letter to the White House, the Advanced Medical Technology Association (AdvaMed) outlined four key priorities in pending regulations for facilities sterilizing medical devices with ethylene oxide (EtO).Continue reading→

Congresswoman Sinema Honored as BIO Legislator of the Year

Posted on Thu/6/AprilThu/6/April by AZBio

Washington, D.C. (April 5, 2017) – The Biotechnology Innovation Organization (BIO) announced today its selection of Congresswoman Kyrsten Sinema (D-AZ) as a 2017 Legislator of the Year. Congresswoman Sinema will receive the award in conjunction with BIO’s Legislative Day Fly-In.

Continue reading→

Bill to Streamline CMS’s Process for Breakthrough Technologies Introduced in the US Senate

Posted on Fri/27/MayFri/27/May by AZBio

The Ensuring Patient Access to Critical Breakthrough Products Act, will help bridge a gap between FDA and CMS and improve patient access to breakthrough medical technologies for serious illnesses, S. 2998, to expedite CMS decision-making for innovative medical technologies.Continue reading→

Life Science Leaders Comment on Medicare Part B Drug Payment Proposed Rule

Posted on Mon/9/MayMon/9/May by AZBio

The Arizona Bioindustry Association (AZBio) together with 42 other state bioindustry associations submited comments to the Centers for Medicare & Medicaid Services’ (CMS’s) Center for Medicare and Medicaid Innovation (CMMI) Medicare Part B Drug Payment Proposed Rule, released March 8, 2016.Continue reading→

Washington Update for March 2016

Posted on Mon/7/MarchFri/25/March by AZBio

Each month, BIO provides the latest updates, issues and poll data on issues affecting our bioscience industry at the national level. Here’s what happened in February 2016.Continue reading→

Congress Suspends The Medical Device Tax for Two Years

Posted on Mon/21/DecemberMon/21/December by AZBio

Medical device innovators got good news on December 18th as  Congress passed a two-year moratorium on a tax the industry said was limiting its growth. Companies and industry backers in Arizona and around the country have worked for years to repeal the 2.3 percent tax on revenue from medical device sales. Continue reading→

BIO The Week That Was – Dec 4, 2015

Posted on Sat/5/DecemberMon/7/December by AZBio

Continue reading→

BIO – The Week That Was Nov. 16-20, 2016

Posted on Sun/22/NovemberMon/7/December by AZBio

Continue reading→

AdvaMedDx Issues Statement on House Diagnostic Test Hearing

Posted on Wed/18/NovemberMon/7/December by AZBio

Andrew Fish, executive director of AdvaMedDx, issued the following statement on today’s House Energy & Commerce Health Subcommittee hearing on the regulation of diagnostic tests and laboratory operations:

Continue reading→

Washington Update – October and November 2015

Posted on Sun/8/NovemberMon/7/December by AZBio

The Washington Update for CSBA is provided to AZBio Members as an update on issues that affect our industry at the nation’s capitol
Continue reading→

Post navigation

1 2 3 4 5 6 Next »

Blog Categories

Upcoming Events

  • AZBio Day at The Capitol
            Feb 18, 2026 - Phoenix
  • Health, Wellness & Sustainability Event
            Feb 21, 2026 - Scottsdale
  • AZBioPEERS: Tales from the Road - Terrence Stull
            Feb 24, 2026 -
  • Unleashing the full power of microarrays
            Feb 24, 2026 -
  • Mfactor Event and Exclusive Movie Screening
            Feb 24, 2026 - Phoenix
  • 2026 Flinn Bio Capital Conference
            Mar 5, 2026 - Phoenix
  • Rare Skeletal Conditions Advocacy Day at the Arizona Capitol
            Mar 16, 2026 - Phoenix
  • CapitalFit Medtech Pitch Event
            Mar 19, 2026 - Scottsdale
  • Children's Health Advocacy Day 2026
            Mar 23, 2026 - Phoenix
  • IdeaFunding 2026
            Mar 26, 2026 - TUCSON
  • Arizona Tech Week - April 6-12
            Apr 6, 2026 -
  • AZAdvances Health Innovation Showcase - AZTECH WEEK
            Apr 7, 2026 - Phoenix
  • Voice of the Patient - AZ TECH WEEK
            Apr 9, 2026 - TUCSON
  • Tucson Symposium 2026
            Apr 15, 2026 - Tucson
  • The Arizona Leadership Summit 2026
            Apr 23, 2026 -
  • World Parkinson Conference - WPC 2026 Phoenix
            May 24, 2026 - Phoenix
  • BIO International Convention
            Jun 22, 2026 - San Diego
  • Rocky Mountain Life Sciences Investor & Partnering Conference
            Sep 30, 2026 - Vail
  • Arizona Bioscience Week
            Oct 5, 2026 -
  • 2026 AZBio Awards
            Oct 7, 2026 - Phoenix
  • all events

Blog Archive

  • Click the image for the latest news about AZBio Members
  • Click the image to learn more about AZBio Membership
  • Click the image to learn more
  • Click the image to enter the AZBio Career Center 
  • Click the image to learn more
  • Click the image to learn more
  • Click the logo to learn more
  • Click the logo to learn more
  • Patients are why we do what we do. Click the image to listen to their stories.

Disclaimer
Imprint
Cookie Policy (CA)
Privacy Policy (CA)

Copyright 2026 | Arizona Bioindustry Association, Inc.
A SiteOrigin Theme
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}